Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOX high mobility group box family member 2 (TOX2) is a protein-coding transcription factor of the high mobility group box (HMG-box) family. TOX2 binds chromatin and functions primarily in the nucleus as a regulator of gene expression, particularly in the positive regulation of transcription by RNA polymerase II. It is preferentially expressed in mature human natural killer (NK) cells and is essential for the late stages of human NK cell development, acting by specifically and directly upregulating the transcription of TBX21 (encoding T-BET), a master transcription factor critical for NK cell maturation and cytotoxic function. TOX2's expression pattern is largely distinct from other family members: it is expressed during later stages of NK cell maturation and not in early NK progenitors. Its deficiency impairs NK cell maturation, notably by reducing T-BET and perforin expression, suggesting a central role in immune homeostasis. TOX2 has also been reported to have expression in reproductive and neural tissues, and is associated with some disease phenotypes, notably cancer pathways (including clear cell renal cell carcinoma) and age-related macular degeneration. Its function as a transcription factor may provide future opportunities for therapeutic modulation, although it is not currently considered a direct therapeutic target for any known drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOX high mobility group box family member 2 (TOX2).